Indo-MIM IPO : GMP, Price Band, Dates & Review

Indo-MIM IPO Details

Indo-MIM IPO is a Mainboard IPO with an issue size of Rs. 3,811.21 Cr by Indo-MIM Limited, comprising a combination of a fresh issue of 1.03 crore shares (Rs. 499.10 Cr) and an offer for sale of 6.83 crore shares (Rs. 3,311.21 Cr).

The Indo-MIM IPO date of opening is 23 Jul 2026; its initial public offering will end on 27 Jul, IPO allotment on Jul 28, and refund initiation on Jul 29, 2026, and the listing date (expected) might be on Thursday, Jul 30, 2026, on the BSE and NSE. 

The Indo-MIM IPO price band is Rs. 461 to Rs. 485.

If you are also looking to apply in this IPO and are confused about whether you should proceed or not, then we have made an analysis in which we will be covering the company’s business, financials, industry trends, valuation, strengths and weaknesses, its current GMP indications, etc that can help you in taking a decision. Keep scrolling.

Indo-MIM IPO - Company Analysis 

Using metal injection molding (MIM) technology, Indo-MIM is a leader in the production of precise engineering components. Mold design, tooling, finishing, and assembly are among the end-to-end solutions that the company provides.

In addition to MIM, the company serves a variety of industries with cutting-edge technologies like investment casting, precision machining, ceramic injection molding, and 3D metal printing. It produced more than 6,400 goods in FY 2025 for the consumer, automotive, defense, medical, and aerospace sectors.

Product Line:

• Automotive
• Defense
• Medical
• Consumer
• Aerospace
  
  

IPO Timetable (Tentative) 

Industry Growth and IT-ITeS Industry Outlook

The global Metal Injection Molding market is projected to reach USD 6.2 billion by CY 2030 from an estimated USD 4 billion in CY 2025, at a CAGR of 9.2% during CY 2025 and 2030.

Click to open demat account and apply for the IPO.

The Objective of the Issue

• Repayment/ prepayment, in full or in part, of all or certain outstanding borrowings availed by the Company. ~ Rs. 400 Cr.
• General Corporate Purposes.
  
  

Promoters And Management of Indo-MIM Ltd.

• Green Meadows Investments Ltd.
• Krishna Chivukula Krishna 
• Chivukula Jr, Raj Chivukula
• Jagadamba C Handrasekhar.

Company Financials 

• The Total Assets (everything the company owns, such as land, machines, cash, and materials) have shown consistent growth over the last three years. As per the Restated Consolidated Financial Information, the Total Assets stood at ₹37,575.13 million as at March 31, 2024, which increased to ₹41,408.41 million as at March 31, 2025, and further rose to ₹48,973.33 million as at March 31, 2026.
  
  
• The Total Income (money earned from main business plus any other income)  has demonstrated strong growth. As per the Restated Consolidated Statement of Profit and Loss, it stood at ₹29,003.82 million for the year ended March 31, 2024, increased to ₹33,739.72 million for FY2025, and further rose to ₹43,207.02 million for FY2026.
  
  
• Profit After Tax (PAT) has grown significantly. As per the Restated Consolidated Financial Information, PAT was ₹2,837.34 million for FY2024, ₹4,237.34 million for FY2025, and ₹5,335.43 million for FY2026.
  
  
• The Profit After Tax (final profit left after paying all costs and taxes) has grown significantly. As per the Restated Consolidated Financial Information, PAT was ₹2,837.34 million for FY2024, ₹4,237.34 million for FY2025, and ₹5,335.43 million for FY2026.
  
  
• The EBITDA (operating profit before deducting interest, taxes, and asset wear-and-tear costs) reflects robust operational performance. As per the Restated Consolidated Financial Information and related notes, EBITDA stood at ₹7,434.62 million for FY2024, ₹9,325.97 million for FY2025, and ₹10,709.23 million for FY2026.
  
  
• The Net Worth (total value belonging to the owners/shareholders of the company) has increased steadily. As per the Restated Consolidated Statement of Assets and Liabilities, it was ₹20,505.11 million as at March 31, 2024, ₹21,994.34 million as at March 31, 2025, and ₹28,195.54 million as at March 31, 2026.
  
  
• The Reserves (profits saved and kept inside the company for future use) form a major component of equity. As per the Restated Consolidated Statement of Assets and Liabilities, Other Equity (primarily Reserves and Surplus) was ₹20,023.08 million as at March 31, 2024, ₹21,512.31 million (approx.) as at March 31, 2025, and ₹27,711.39 million as at March 31, 2026.
  
  
• The Total Borrowings (total loans and debt taken by the company) show a moderated increase amid growth. As per the Restated Consolidated Statement of Assets and Liabilities, it stood at ₹10,850.12 million (approx.) as at March 31, 2024, ₹12,471.95 million as at March 31, 2025, and ₹10,904.88 million as at March 31, 2026.
  
  

Financials Snapshot

(Amount in Cr)

Cash Flows

• The Net Cash Flow from Operating Activities (cash generated from the company’s main day-to-day business after adjusting for working capital and taxes) stood at ₹4,523.32 million for the year ended March 31, 2024, which increased to ₹5,062.71 million for the year ended March 31, 2025, and further rose to ₹10,772.41 million for the year ended March 31, 2026.
  
  
• Net Cash Flow from Investing Activities (cash used for buying/selling long-term assets like machinery, property, or investments) stood at ₹(4,755.07) million for FY2024, improved to ₹(3,359.26) million for FY2025, and was ₹(5,365.53) million for FY2026.
  
  
• Net Cash Flow from Financing Activities (cash from loans, repayments, share issuance, and interest payments) was ₹(928.77) million for FY2024, ₹(3,975.36) million for FY2025, and ₹(3,360.82) million for FY2026.
  
  

Cash Flows Snapshot

(Amount in Mn)

Revenue Bifurcation

(Source: RHP)

Listed Peers of Indo-MIM Ltd. 

Valuation

• The Return on Capital Employed (RoCE), which measures how efficiently the Company generates earnings before interest and taxes from the capital employed, stood at 26.60% for the year ended March 31, 2026.
  
  
• The Debt/Equity Ratio (Net Debt to Equity), which indicates the proportion of debt used by the Company relative to shareholders’ equity, was 0.39 times as at March 31, 2026.
  
  
• The Return on Net Worth (RoNW), which shows the return generated on the shareholders’ funds, was 21.26% for FY 2026.
  
  
• The PAT Margin (Profit After Tax Margin), which represents the percentage of revenue that remains as profit after all expenses and taxes, stood at 12.72% for FY 2026.
  
  
• The Operating EBITDA Margin, which indicates the operating profitability of the core business before interest, taxes, depreciation and amortisation, was 25.54% for FY 2026. 
  
  

Valuation Snapshot

Is Valuation Expensive?

The P/E ratio for the Indo-MIM IPO stands at 43.85x based on FY26 EPS of ₹11.06 at the upper price band. This appears relatively moderate when compared to the listed peer Jiangsu Gian Technology, which has a much higher PE of 148x. The company also reports healthy margins and returns, with ROCE at 26.60%, ROE at 21.26%, and low Debt/Equity of 0.39x.

Evaluation of P/E Ratio

Considering the period ended FY 2026 with an EPS of Rs. 11.06 from the last year, the resulting P/E ratio is 43.85x.

Explore the Xtranet Technologies IPO.

IPO's Strengths / Bull Case

• Global leadership in manufacturing precision engineering components using MIM technology.
• Long-standing relationships with Indian and global OEM customers.
• Diversified product portfolio catering to applications across multiple industries.
• Backward-integrated, dual-shore manufacturing capabilities with focus on efficiency.
  
  

IPO's Weaknesses / Bear Case

• No Long-Term Customer Commitments.
• Raw Material Import Dependence.
• Manufacturing Disruption Risk.
  
  

Future Opportunities

• An increasing number of automotive applications
• Growing demand for miniaturization of electronic devices, such as smartphones, laptops, and wearables.
• Provides quality and accuracy for medical devices 
• Focused growth of consumer electronics.

Indo-MIM IPO GMP

Indo-MIM IPO GMP today is Rs. 205 as of 20 July 2026, while writing this information. With the upper price band of Rs. 485, Indo-MIM IPO's estimated listing price is Rs. 690. The expected listing gain/loss per share is 42.27%.

Anchor Investors

Details of anchor participation (if any) would be available in filings; pre-IPO investors include entities like Anchorage Capital and Baring PE.

Subscription Status (Live)

Subscription data will be available during/after the issue period on the BSE/NSE websites. Check official sources for real-time updates.

Indo-MIM IPO Lesser-Known Facts

• IIT Madras Connection: Indian Institute of Technology Madras is one of the Selling Shareholders in the IPO, offering shares (up to 2,307,700 Equity Shares).
  
  
• Cost-audit compliance matters are still pending: The MCA issued show-cause notices alleging failure to appoint a cost auditor for FY2022, FY2023 and FY2024. Indo-MIM argues that it qualified for an export-based exemption, but the matters were pending as of the RHP date.
  
  
• The Chairman was previously disqualified from holding directorships: Chairman and Managing Director Krishna Chivukula was disqualified from directorship from November 1, 2016, to October 31, 2021, in connection with another company that was struck off by the Registrar of Companies.
  
  
• Auditors included emphasis-of-matter and negative CARO observations: Although the financial statements for FY2024-FY2026 did not contain audit qualifications, the statutory auditors included emphasis-of-matter observations for FY2024 and FY2025 and certain negative remarks under CARO for the reviewed years.
  
  
• Legal and regulatory proceedings involve significant amounts: The RHP lists 40 tax proceedings and five statutory or regulatory proceedings against the company, involving an aggregate quantifiable amount of approximately ₹421.25 crore. One criminal proceeding was also disclosed against a director.
  
  
• The industry report supporting market-leadership claims was company-funded: The Frost & Sullivan industry report used in the RHP was exclusively commissioned and paid for by Indo-MIM for the IPO. Its claims—including Indo-MIM’s estimated 6.8% global MIM market share—should therefore be read with this disclosure in mind.
  
  

Who Should Avoid this IPO? / Who Should Apply?

Investors can weigh factors, along with financial growth trends (rising revenue, PAT, EBITDA, and strong operating cash flows), industry CAGR projections (9.2% for the global MIM market), GMP indications, and their individual risk appetite and due diligence.

Indo-MIM IPO Summary

IPO Lot Details 

Indo-MIM IPO Allotment Status

To check the Indo-MIM IPO Allotment Status, visit the official Registrar’s website or the BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

IPO Lead Managers

• HDFC Bank Ltd.
  
  

Dividend Policy

The company has paid a Dividend of Rs. 3.30 and Rs. 3.50 per equity share as the second interim dividend and first interim dividend in FY26.

Should You Apply for Indo-MIM IPO?

Investors are advised to review the full RHP, the latest GMP, and subscription trends, and consult SEBI-registered professionals before taking any decision. Different investor categories may evaluate scale, valuation, risks, and opportunities differently.

Conclusion

Indo-MIM IPO presents strong financial growth, healthy profitability, robust operating cash flow, and leadership in the expanding metal injection moulding industry. However, the IPO is priced at a relatively high valuation and carries risks related to customer concentration, raw material imports, regulatory proceedings, and the large offer-for-sale component.

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the company, click here to download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.